CORAL GABLES, FL / ACCESSWIRE / February 23, 2015 / Apps are starting to become more sophisticated and with that, the limits continue to push far beyond simple text or media messaging. This positions many "next level" investors to keep building wealth in"the cutting edge" and they continue to find the tech space a familiar place to do so. According to Gartner Research for example, by 2017 mobile apps alone will generate $77 billion in revenues and would be downloaded an eye opening 268 billion times. So, in today's marketplace, investors are catching onto the growth potential in an already exploding marketplace: Technology.

Eventure Interactive (OTC:EVTI) has begun to see a flurry of buying during the last 2 trading sessions. Since last week, the stock has bounced back by nearly 80% as of the high on Friday. Eventure develops unique applications to complement already existing software or to bring new apps to market. In the near-term, EVTI has focused on its Eventure application to offer its users an engaging way to share life moments with friends, family, and others.

MyEcheck, Inc (OTCPINK:MYEC) has also seen an incredible rally since late January lows. Over the last 3 weeks, the stock price for MYEC has rallied by as much as 67% after Thursday morning trading took the price to highs of $0.0239; a price this stock has not seen since the beginning of the year. Recently the company announced that it has signed an agreement to acquire 100% of the stock of Seergate, developer of a comprehensive electronic payment software platform for banks, in exchange for a minimum $3 M in shares of MyECheck common stock. The Seergate system will be integrated with the MyECheck payment systems adding multiple new capabilities to MyECheck's payment platform.

Though there's no special application under development, no technology overview would be complete without discussing one a company that's in one of the quickest growing niches of the tech space, which is biotechnology. Eastgate Biotech (OTC:ETBI) is an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules. The company provided an update to its patent portfolio where the company recently expanded its new pharmaceutical product development to include large molecules as active compounds that will address indications in diabetes, obesity and the overall metabolic syndrome. Since mid-week last week, shares of ETBI have bounce from $0.025 to highs of $0.0322 on Friday.

ABOUT US:

www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts.

Subscribe Here: http://www.DailyStockReporter.com/

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. EGM FIRM INC which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

CONTACT:

Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com


SOURCE: Daily Stock Reporter